Patented closure system enhances safety and user friendliness

Frankfurt, October 25, 2011 - Gerresheimer is a global technology leader for sterile RTF^® (ready-to-fill) glass syringes. Numerous pharma companies today prefer to purchase prefillable syringes as ready-to-fill rather than bulk products.

Syringe accessories that enhance user friendliness and system safety are becoming increasingly important these days. The Gerresheimer TELC^® (Temper Evident Luer Lock Closure) is a unique patented Luer Lock closure, which combines the standard function of a conventional Luer Lock syringe plus tip cap with an additional tamper evident function.

Gerresheimer has patented this system and it holds the exclusive production, marketing and sales rights. The TELC^® system is available around the world without restrictions.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion Euros and has 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

Contact
Jens Kürten
Director Corporate Communication & Marketing  
Phone +49 211 6181-250 
Fax +49 211 6181-241 
E-Mail: please click

Marion Stolzenwald
Senior Manager Corporate Communication
Phone +49 211 6181-246
Fax +49 211 6181-28246 
E-Mail: please click